D. E. Shaw & Co., Inc. - AIMMUNE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$535,000
-83.8%
15,530
-92.1%
0.00%
-75.0%
Q2 2020$3,293,000
+1771.0%
197,048
+1515.1%
0.00%
Q1 2020$176,000
-83.2%
12,200
-61.0%
0.00%
-100.0%
Q4 2019$1,049,000
+387.9%
31,315
+57.8%
0.00%
Q2 2016$215,00019,8490.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders